Form 4 OKYO Pharma Ltd For: 29 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
OKYO Pharma (OKYO)
Track the OKYO Pharma Ltd share price today and view real-time OKYO share price data, including charts, technicals, and key financials. View the OKYO premarket stock price ahead of the market session or assess the after hours quote. Explore OKYO stock price movements, trading volume, and market activity across the NASDAQ exchange.
What Is the OKYO Pharma Ltd Stock Price Today?
The OKYO Pharma Ltd stock price today is 1.665.
What Is the Stock Symbol for OKYO Pharma Ltd?
The stock symbol for OKYO Pharma Ltd is ""OKYO.""
What Stock Exchange Does OKYO Pharma Ltd Trade On?
OKYO Pharma Ltd is listed and trades on the NASDAQ stock exchange.
Is OKYO Pharma Ltd a Good Stock to Buy?
Determining whether OKYO Pharma Ltd or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OKYO quote. (ISIN: GG00BMFG5F62)
What Is the OKYO Pharma Ltd Stock Price Today?
The OKYO Pharma Ltd stock price today is 1.665.
What Is the Stock Symbol for OKYO Pharma Ltd?
The stock symbol for OKYO Pharma Ltd is ""OKYO.""
What Stock Exchange Does OKYO Pharma Ltd Trade On?
OKYO Pharma Ltd is listed and trades on the NASDAQ stock exchange.
Is OKYO Pharma Ltd a Good Stock to Buy?
Determining whether OKYO Pharma Ltd or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the OKYO quote. (ISIN: GG00BMFG5F62)
1.665
-0.015(-0.89%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.650
1.690
52 wk Range
1.340
3.349
OKYO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.6501.690
52 wk Range
1.3403.349
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
OKYO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
8.333
Upside
+400.50%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
OKYO Pharma CSO purchases additional shares at $1.49- Investing.com
OKYO Pharma director buys 3,500 shares at $1.40 each- Investing.com
- Form 4 OKYO Pharma Ltd For: 29 July
- Investing.com
- OKYO Pharma CSO purchases additional shares at $1.49
- Investing.com
Form 4 OKYO Pharma Ltd For: 24 July- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 8.333
(+400.50% Upside)
Earnings
Latest Release
03/06/2026
EPS / Forecast
-0.03 / -0.08
Revenue / Forecast
-- / --
Compare OKYO to Peers and Sector
Metrics to compare | OKYO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOKYOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.8x | −5.5x | −0.4x | |
PEG Ratio | 0.10 | 0.05 | 0.00 | |
Price/Book | 7.1x | 3.6x | 2.6x | |
Price / LTM Sales | - | 6.8x | 3.0x | |
Upside (Analyst Target) | 324.2% | 125.1% | 56.0% | |
Fair Value Upside | Unlock | 7.8% | 9.1% | Unlock |
OKYO Pharma Limited, a clinical-stage biopharmaceutical company, develops therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead clinical product candidate is urcosimod, which is in Phase II clinical trials for the treatment of dry eye disease; in Phase II clinical trial to treat neuropathic corneal pain; and is in preclinical trial to treat allergic conjunctivitis and uveitis. The company is also developing OK-201 for the treatment acute and chronic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the OKYO Pharma Ltd (OKYO) Stock Price Today?
The OKYO Pharma Ltd stock price today is 1.665 USD.
What Stock Exchange Does OKYO Pharma Ltd Trade On?
OKYO Pharma Ltd is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for OKYO Pharma Ltd?
The stock symbol for OKYO Pharma Ltd is "OKYO."
What Is the OKYO Pharma Ltd Market Cap?
As of today, OKYO Pharma Ltd market cap is 87.380M USD.
What Is OKYO Pharma Ltd's Earnings Per Share (TTM)?
The OKYO Pharma Ltd EPS (TTM) is -0.240.
When Is the Next OKYO Pharma Ltd Earnings Date?
OKYO Pharma Ltd will release its next earnings report on 02/09/2026.
From a Technical Analysis Perspective, Is OKYO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has OKYO Pharma Ltd Stock Split?
OKYO Pharma Ltd has split 2 times.
How Many Employees Does OKYO Pharma Ltd Have?
OKYO Pharma Ltd has 5 employees.
What is the current trading status of OKYO Pharma Ltd (OKYO)?
As of 03/08/2026, OKYO Pharma Ltd (OKYO) is trading at a price of 1.665 USD, with a previous close of 1.680 USD. The stock has fluctuated within a day range of 1.650 USD to 1.690 USD, while its 52-week range spans from 1.340 USD to 3.349 USD.
What Is OKYO Pharma Ltd (OKYO) Price Target According to Analysts?
The average 12-month price target for OKYO Pharma Ltd is 8.333 USD, with a high estimate of 13 USD and a low estimate of 5 USD. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +400.50% Upside potential.
What Is the OKYO Premarket Price?
OKYO's last pre-market stock price is 1.690 USD. The pre-market share volume is 50.000, and the stock has decreased by 0.010, or 0.600%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.